Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.9B | 2.9B | 2.8B | 2.8B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 318M | 419M | 355M | 302M |
| Other operating expenses | 539M | 55M | 47M | 2M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 747M | 1.0B | 1.1B | 1.2B |
| Tax provision | 202M | -96M | 211M | 237M |
| Net income | 546M | 1.1B | 868M | 925M |
| Basic EPS | 1.3 | 2.8 | 2.1 | 2.3 |
| Diluted EPS | 1.3 | 2.8 | 2.1 | 2.3 |
| Basic average shares | 397M | 405.8M | 405.6M | 411.1M |
| Diluted average shares | 397M | 405.8M | 405.6M | 411.1M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 747M | 1.0B | 1.1B | 1.2B |
| Minority interests | 0 | 0 | 0 | 0 |
| Preferred stock dividends | 23M | — | — | — |